Catalyst Wire Dossier Catalyst Wire Dossier

ParaGard

copper intrauterine device · Teva Pharmaceutical Industries
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for ParaGard, covering 2009-08-06 to 2026-08-25. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive) [Phase 4]

See pricing